Hemp-Derived Cannabinoids for Menopause
What You Need to Know Before You Apply
What is the purpose of this trial?
The purpose of the study is to examine the impact of hemp-derived minor cannabinoids on symptoms of menopause/perimenopause.
Are You a Good Fit for This Trial?
This trial is for women experiencing menopause or perimenopause symptoms. It's not specified who can't join, but typically people with certain health conditions or those taking medications that could interfere with the study might be excluded.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline
Participants complete four weeks of baseline assessments via ecological momentary assessment (EMA) and cognitive tests
Phase 1
Participants take the active or placebo product three times a day and complete EMA survey assessments twice a day
Phase 2
Continuation of product administration and EMA assessments as in Phase 1
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Hemp-Derived Cannabinoids
Trial Overview
The study is testing hemp-derived cannabinoids against a placebo to see if they help with menopause symptoms like anxiety and mental fatigue. Participants won't know which one they're getting.
How Is the Trial Designed?
2
Treatment groups
Active Control
Placebo Group
Participants in this arm will receive an active product.
Participants in this arm will receive a placebo.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Washington State University
Lead Sponsor
Terra Mater Botanicals Pty Ltd
Collaborator
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.